Search This Blog

Monday, June 24, 2024

Sarepta Therapeutics, Inc.: Mizuho Securities upgrades to outperform from buy

  price target raised from USD 179 to USD 200.

https://www.marketscreener.com/quote/stock/SAREPTA-THERAPEUTICS-INC-11204214/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.